Objective Scleroderma patients with autoantibodies to centromere proteins (CENPs) and/or interferon-inducible protein 16 (IFI16) are at increased risk of severe vascular complications. cells in biopsies from scleroderma patients and CUDC-907 normal controls. Flow cytometry analysis revealed IFI16 expression in CPCs, but minimal expression in CECs. Conclusion Expression of scleroderma autoantigens IFI16 and CENPs, which are… Continue reading Objective Scleroderma patients with autoantibodies to centromere proteins (CENPs) and/or interferon-inducible